Reviews: Focus On Metabolismand Immunology
Reviews: Focus On Metabolismand Immunology
REVIEWS
Abstract | The worldwide epidemic of obesity has brought considerable attention to
research aimed at understanding the biology of adipocytes (fat cells) and the events
occurring in adipose tissue (fat) and in the bodies of obese individuals. Accumulating
evidence indicates that obesity causes chronic low-grade inflammation and that this
contributes to systemic metabolic dysfunction that is associated with obesity-linked
disorders. Adipose tissue functions as a key endocrine organ by releasing multiple
bioactive substances, known as adipose-derived secreted factors or adipokines, that
have pro-inflammatory or anti-inflammatory activities. Dysregulated production or
secretion of these adipokines owing to adipose tissue dysfunction can contribute to
the pathogenesis of obesity-linked complications. In this Review, we focus on the
role of adipokines in inflammatory responses and discuss their potential as regulators
of metabolic function.
REVIEWS
Figure 1 | Adipose tissue depots. Adipose tissue is mainly found in subcutaneous
and visceral depots. Under conditions of obesity, adipose tissue expands in these and
other depots throughout the body. Common sites of adipose tissue accumulation
include the heart, the kidneys and the adventitia of blood vessels. Differential
adipokine secretion by various adipose tissue depots may selectively affect organ
function and systemic metabolism.
F O C U S O N M E TA B O L I S M A N D I M MURNEOVLO
IEWGY
S
REVIEWS
Pro-inflammatory adipokines
Figure 2 | Components of adipose tissue. a | Adipocytes are the main cellular
component of adipose tissue, and they are crucial for both energy storage and
endocrine activity. The other cell types that are present are precursor cells (including
pre-adipocytes), fibroblasts, vascular cells and immune cells, and these cells constitute the
stromal vascular fraction of adipose tissue. Vascular cells include both endothelial cells
and vascular smooth muscle cells, which are associated with the major blood vessels. The
blood vessels in adipose tissue are required for the proper flow of nutrients and oxygen
to adipocytes, and they are the conduits that allow for the distribution of adipokines.
Vascular cells also secrete, and are responsive to, adipose tissue-secreted proteins.
Other active adipose tissue components include macrophages and T cells, which have
major roles in determining the immune status of adipose tissue. The fibroblast-derived
extracellular matrix functions to provide mechanical support, and excess matrix can
lead to adipose tissue dysfunction. Factors that are secreted by these different cellular
components are critical for maintaining homeostasis in adipose tissue and throughout
the body. b | Examples of intercellular communication between different adipose tissue
cell types include the counter-regulation between adiponectin and tumour necrosis
factor (TNF), and between secreted frizzled-related protein 5 (SFRP5) and WNT5a.
Under conditions of obesity the pro-inflammatory factors (TNF and WNT5a) predominate.
F O C U S O N M E TA B O L I S M A N D I M MURNEOVLO
IEWGY
S
REVIEWS
Figure 3 | Phenotypic modulation of adipose tissue. Adipose tissue can be described by at least three structural and
functional classifications: lean with normal metabolic function, obese with mild metabolic dysfunction and obese with full
metabolic dysfunction. As obesity develops, adipocytes undergo hypertrophy owing to increased triglyceride storage. With
limited obesity, it is likely that the tissue retains relatively normal metabolic function and has low levels of immune cell activation
and sufficient vascular function. However, qualitative changes in the expanding adipose tissue can promote the transition to a
metabolically dysfunctional phenotype. Macrophages in lean adipose tissue express markers of an M2 or alternatively activated
state, whereas obesity leads to the recruitment and accumulation of M1 or classically activated macrophages, as well as T cells,
in adipose tissue. Anti-inflammatory adipokines, including adiponectin and secreted frizzled-related protein 5 (SFRP5), are
preferentially produced by lean adipose tissue. In states of obesity, adipose tissue generates large amounts of pro-inflammatory
factors, including leptin, resistin, retinol-binding protein 4 (RBP4), lipocalin 2, angiopoietin-like protein 2 (ANGPTL2), tumour
necrosis factor (TNF), interleukin-6 (IL-6), IL-18, CC-chemokine ligand 2 (CCL2), CXC-chemokine ligand 5 (CXCL5) and
nicotinamide phosphoribosyltransferase (NAMPT). Obese individuals with adipose tissue in a metabolically intermediate state
have improved metabolic parameters, diminished inflammatory marker expression and better vascular function compared with
individuals that have metabolically dysfunctional adipose tissue. Metabolically dysfunctional adipose tissue can be associated
with higher levels of adipocyte necrosis, and M1 macrophages are arranged around these dead cells in crown-like structures.
F O C U S O N M E TA B O L I S M A N D I M MURNEOVLO
IEWGY
S
REVIEWS
Anti-inflammatory adipokines
F O C U S O N M E TA B O L I S M A N D I M MURNEOVLO
IEWGY
S
REVIEWS
Concluding remarks
Box 3 | Adiponectin and inflammatory lung disease
A baseline phenotype of adiponectin-deficient mice is emphysema-like dilated
airspaces and alveolar macrophage activation176. In addition, adiponectin-deficient
mice develop a pulmonary hypertension phenotype that is associated with perivascular
inflammation177,178. Obesity is a risk factor for the development of asthma, and
micro-pump administration of recombinant adiponectin is reported to reduce allergic
lung inflammation in an asthma model of ovalbumin sensitization and challenge179. Little
is known about the mechanisms by which adiponectin suppresses inflammation in the
lungs. Adiponectin receptor 1 is expressed by lung epithelial cells180, and T
T-cadherin
seems to be required to facilitate the entry of adiponectin into the lungs181. Whereas
expression of adiponectin is reduced in subjects who smoke cigarettes, increased levels
are found in those with chronic obstructive pulmonary disease180 and high levels of
adiponectin are associated with mortality in patients with respiratory failure182.
F O C U S O N M E TA B O L I S M A N D I M MURNEOVLO
IEWGY
S
REVIEWS
F O C U S O N M E TA B O L I S M A N D I M MURNEOVLO
IEWGY
S